| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8774747 | Nefrología | 2017 | 8 Pages |
Abstract
We didn't find any advantages to using bioPTH vs. PTHi as a marker of mortality. BioPTH limits of normality must be reevaluated because its relationship with iPTH is not consistent. Not knowing these limits affects its prognostic value.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Laura RodrÃguez-Osorio, Concepción de la Piedra, Mercedes Rubert, Marta MartÃn-Fernández, MarÃa Luisa González Casaus, Carolina Gracia-Iguacel, Jesús Egido, Ricardo Villa-Bellosta, Emilio González Parra,